UB Paderborn / Katalog / Suche / in CDI

The principal toxic glycosidic steroids in Cerbera manghas L. seeds: Identification of cerberin, neriifolin, tanghinin and deacetyltanghinin by UHPLC–HRMS/MS, quantification by UHPLC–PDA-MS

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014-07, Vol.962, p.1-8

2014

Link zum Volltext

Verfügbarkeit prüfen

Fatal Case of a 27‐Year‐Old Male After Taking Iboga in Withdrawal Treatment: GC‐MS/MS Determination of Ibogaine and Ibogamine in Iboga Roots and Postmortem Biological Material

Journal of forensic sciences, 2013-11, Vol.58 (6), p.1666-1672

2013

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol Adverse Effects and Toxicity

Current neuropharmacology, 2019-01, Vol.17 (10), p.974-989

2019

Link zum Volltext

Verfügbarkeit prüfen

Atropine Eye Drops: An Unusual Homicidal Poisoning

Journal of forensic sciences, 2014-05, Vol.59 (3), p.859-864

2014

Link zum Volltext

Verfügbarkeit prüfen

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances

Frontiers in psychiatry, 2020-10, Vol.11, p.584462-584462

2020

Link zum Volltext

Verfügbarkeit prüfen

Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair

Frontiers in chemistry, 2019-04, Vol.7, p.184-184

2019

Link zum Volltext

Verfügbarkeit prüfen

Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations

International journal of molecular sciences, 2020-12, Vol.22 (1), p.230

2020

Link zum Volltext

Verfügbarkeit prüfen

Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review

Current neuropharmacology, 2023-01, Vol.21 (11), p.2323-2342

2023

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid

Current neuropharmacology, 2017-07, Vol.15 (5), p.682-691

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes

The AAPS journal, 2017-03, Vol.19 (2), p.568-577

2017

Link zum Volltext

Verfügbarkeit prüfen

Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS

Metabolites, 2023-08, Vol.13 (8), p.949

2023

Link zum Volltext

Verfügbarkeit prüfen

A validated method for quantifying hypoglycin A in whole blood by UHPLC–HRMS/MS

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2015-01, Vol.978-979, p.70-77

2015

Link zum Volltext

Verfügbarkeit prüfen

Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study

Pharmaceuticals (Basel, Switzerland), 2024-02, Vol.17 (2), p.249

2024

Link zum Volltext

Verfügbarkeit prüfen

Human Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry

Metabolites, 2022-07, Vol.12 (8), p.705

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection

Journal of pharmaceutical and biomedical analysis, 2018-08, Vol.157, p.27-35

2018

Link zum Volltext

Verfügbarkeit prüfen

In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites

Talanta (Oxford), 2021-12, Vol.235, p.122740-122740, Article 122740

2021

Link zum Volltext

Verfügbarkeit prüfen

Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry

Clinical chemistry (Baltimore, Md.), 2017-05, Vol.63 (5), p.1008-1021

2017

Link zum Volltext

Verfügbarkeit prüfen

3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022-03, Vol.1193, p.123162, Article 123162

2022

Link zum Volltext

Verfügbarkeit prüfen

In silico and in vitro human metabolism of IOX2, a performance-enhancing doping agent

Journal of pharmaceutical and biomedical analysis, 2024-01, Vol.238, p.115759-115759, Article 115759

2024

Link zum Volltext

Verfügbarkeit prüfen

Development of an enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of methorphan and its O-demethylated metabolite in human blood and its application to post-mortem samples

Journal of pharmaceutical and biomedical analysis, 2023-06, Vol.230, p.115384-115384, Article 115384

2023

Link zum Volltext

Verfügbarkeit prüfen

Human Hepatocyte Metabolism of Novel Synthetic Cannabinoids MN-18 and Its 5-Fluoro Analog 5F-MN-18

Clinical chemistry (Baltimore, Md.), 2017-11, Vol.63 (11), p.1753-1763

2017

Link zum Volltext

Verfügbarkeit prüfen

In vitro, in vivo and in silico metabolic profiling of -pyrrolidinopentiothiophenone, a novel thiophene stimulant

Bioanalysis, 2016, Vol.8 (1), p.65

2016

Link zum Volltext

Verfügbarkeit prüfen

25C‐NBOMe and 25I‐NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high‐resolution mass spectrometry

Drug testing and analysis, 2017-05, Vol.9 (5), p.680-698

2017

Link zum Volltext

Verfügbarkeit prüfen

Quantification of hypoglycin A in serum using aTRAQ® assay

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2015-08, Vol.997, p.75-80

2015

Link zum Volltext

Verfügbarkeit prüfen

Human Hepatocyte 4-Acetoxy-IN/I,IN/I-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry

Metabolites, 2022-07, Vol.12 (8)

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The principal toxic glycosidic steroids in Cerbera manghas L. seeds: Identification of cerberin, neriifolin, tanghinin and deacetyltanghinin by UHPLC–HRMS/MS, quantification by UHPLC–PDA-MS

Fatal Case of a 27‐Year‐Old Male After Taking Iboga in Withdrawal Treatment: GC‐MS/MS Determination of Ibogaine and Ibogamine in Iboga Roots and Postmortem Biological Material

Cannabidiol Adverse Effects and Toxicity

Atropine Eye Drops: An Unusual Homicidal Poisoning

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances

Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair

Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations

Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review

In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid

Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes

Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS

A validated method for quantifying hypoglycin A in whole blood by UHPLC–HRMS/MS

Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study

Human Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry

Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection

In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites

Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry

3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining

In silico and in vitro human metabolism of IOX2, a performance-enhancing doping agent

Development of an enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of methorphan and its O-demethylated metabolite in human blood and its application to post-mortem samples

Human Hepatocyte Metabolism of Novel Synthetic Cannabinoids MN-18 and Its 5-Fluoro Analog 5F-MN-18

In vitro, in vivo and in silico metabolic profiling of -pyrrolidinopentiothiophenone, a novel thiophene stimulant

25C‐NBOMe and 25I‐NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high‐resolution mass spectrometry

Quantification of hypoglycin A in serum using aTRAQ® assay

Human Hepatocyte 4-Acetoxy-IN/I,IN/I-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry

Aktive Filter

Suchergebnisse filtern